Stem Cells International · 2018 · 40 citations · 33 references
MedicineImmunologyOrthopedic SurgeryBone MetabolismRegenerative MedicineRheumatologyBone HealingBone RegenerationBone Regeneration BiologyBone TissueMesenchymal Stem Cell TherapyOsteogenesisBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsCell-based Bone TherapyCollagen-induced ArthritisOsteogenic DifferentiationOsteogenic MarkersTransplantationUmbilical Cord-derived Mesenchymal Stem Cells
Objective . To investigate the effects of umbilical cord mesenchymal stem cell (UC-MSC) transplantation on joint damage and osteoporosis in collagen-induced arthritis (CIA) mice and to explore the mechanisms by which UC-MSCs modulate the osteogenic differentiation. Methods . CIA mice were divided into the following treated groups: UC-MSC transplantation group, antitumor necrosis factor- (TNF-) α group, and zoledronic acid (ZA) group. Microcomputed tomography (micro-CT) was used to analyze the bone morphology parameters. Osteogenic differentiation of treated CIA mice was determined. Bone marrow mesenchymal stem cells (BM-MSCs) from CIA mice were treated with TNF- α in vitro to explore their effects on osteogenesis. Results . The arthritis score was significantly reduced in the UC-MSC transplantation and anti-TNF- α -treated CIA groups, compared with control mice (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>). Micro-CT showed that CIA mice developed osteoporosis at 12 weeks after immunization. The bone morphology parameters were partially improved in UC-MSC-treated CIA mice. Impaired osteogenic differentiation functions were indicated by decreased ALP activity (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>) and reduced mRNA and protein levels of osteogenic marker genes (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.05</mml:mn></mml:math>) in CIA mice compared with DBA/1 mice. UC-MSC treatment significantly upregulated the impaired osteogenic differentiation ability in CIA mice. Meanwhile, the serum TNF- α level was decreased significantly in the UC-MSC group. The osteogenesis was reduced with the addition of TNF- α in vitro. Conclusion . This study demonstrated that UC-MSC transplantation not only significantly improved the joint damage but also played a beneficial role in osteoporosis in CIA mice. Mechanistically, the improved osteogenic differentiation of CIA under UC-MSC treatment may be achieved by inhibition of TNF- α .
33
Multilineage Potential of Adult Human Mesenchymal Stem Cells
Mark F. Pittenger, Alastair M. Mackay, Stephen C. Beck et al. · Science · 1999 · 21.1K citations
Human mesenchymal stem cells modulate B-cell functions
Anna Corcione, Federica Benvenuto, Elisa Ferretti et al. · Blood · 2005 · 1.8K citations · Full text
David Brand, Kary A. Latham, Edward F. Rosloniec · Nature Protocols · 2007 · 1.4K citations
IL-1 mediates TNF-induced osteoclastogenesis
Wei Shi, Hideki Kitaura, Ping Zhou et al. · Journal of Clinical Investigation · 2005 · 671 citations · Full text